David J. DeBrota

1.3k total citations
26 papers, 948 citations indexed

About

David J. DeBrota is a scholar working on Pharmacology, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, David J. DeBrota has authored 26 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Cognitive Neuroscience and 7 papers in Experimental and Cognitive Psychology. Recurrent topics in David J. DeBrota's work include Treatment of Major Depression (11 papers), Mental Health Research Topics (7 papers) and Statistical Methods and Bayesian Inference (4 papers). David J. DeBrota is often cited by papers focused on Treatment of Major Depression (11 papers), Mental Health Research Topics (7 papers) and Statistical Methods and Bayesian Inference (4 papers). David J. DeBrota collaborates with scholars based in United States, Australia and Canada. David J. DeBrota's co-authors include William Z. Potter, Mark A. Demitrack, John M. Herrera, Douglas E. Faries, Robert S. Dittus, Craig Mallinckrodt, Gary D. Tollefson, Geert Molenberghs, Raymond J. Carroll and T.M. Sanger and has published in prestigious journals such as Management Science, Biological Psychiatry and Journal of Computational Physics.

In The Last Decade

David J. DeBrota

26 papers receiving 896 citations

Peers

Countries citing papers authored by David J. DeBrota

Since Specialization

Citations

This map shows the geographic impact of David J. DeBrota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. DeBrota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. DeBrota more than expected).

Fields of papers citing papers by David J. DeBrota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. DeBrota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. DeBrota. The network helps show where David J. DeBrota may publish in the future.

Co-authorship network of co-authors of David J. DeBrota

This figure shows the co-authorship network connecting the top 25 collaborators of David J. DeBrota. A scholar is included among the top collaborators of David J. DeBrota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. DeBrota. David J. DeBrota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum Lipid and Protein Changes in Healthy Dyslipidemic Subjects Given a Selective Inhibitor of p70 S6 Kinase‐1 2017 ·The Journal of Clinical Pharmacology ·Jennifer Leohr, Debra Luffer‐Atlas, Mengdie Luo, David J. DeBrota, Colin Green, Thomas E. Mabry, Jeffrey G. Suico	2
2	Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects 2014 ·British Journal of Clinical Pharmacology ·Christopher D. Payne, Mark A. Deeg, Melanie Chan, (unknown), Elizabeth LaBell, Tong Shen, David J. DeBrota	31
3	Site Versus Centralized Raters in a Clinical Depression Trial 2010 ·Journal of Clinical Psychopharmacology ·Kenneth A. Kobak, Andrew F. Leuchter, David J. DeBrota, Nina Engelhardt, Janet B. W. Williams, Ian A. Cook, Andrew C. Leon, Jonathan E. Alpert	53
4	Changes in Brain Function during Administration of Venlafaxine or Placebo to Normal Subjects 2008 ·Clinical EEG and Neuroscience ·Andrew F. Leuchter, Ian A. Cook, David J. DeBrota, Aimee M. Hunter, William Z. Potter, (unknown), Melinda Morgan, Michelle Abrams, (unknown)	25
5	Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos 2007 ·Depression and Anxiety ·Darcy A. Santor, David J. DeBrota, Nina Engelhardt, (unknown)	10
6	AN INTEGRATIVE APPROACH TO DETERMINE THE BEST BEHAVIORAL AND BIOLOGICAL MARKERS OF METHYLPHENIDATE 2007 ·Journal of Integrative Neuroscience ·Daniel F. Hermens, Nicholas Cooper, C. Richard Clark, David J. DeBrota, Simon D. Clarke, Leanne M. Williams	18
7	Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET). 2007 ·PubMed ·James C. Mundt, David J. DeBrota, John H. Greist	7
8	An Examination of 26,168 Hamilton Depression Rating Scale Scores Administered via Interactive Voice Response Across 17 Randomized Clinical Trials 2006 ·Journal of Clinical Psychopharmacology ·(unknown), James C. Mundt, Jack G. Modell, (unknown), David J. DeBrota, (unknown), John H. Greist	19
9	Rating the Raters 2006 ·Journal of Clinical Psychopharmacology ·Nina Engelhardt, Alan D. Feiger, Kenneth O. Cogger, (unknown), David J. DeBrota, Joshua D. Lipsitz, Kenneth A. Kobak, Kenneth Evans, William Z. Potter	25
10	THE DOSE-DEPENDENT EFFECT OF METHYLPHENIDATE ON PERFORMANCE, COGNITION AND PSYCHOPHYSIOLOGY 2005 ·Journal of Integrative Neuroscience ·Nicholas Cooper, Hannah A. D. Keage, Daniel F. Hermens, Leanne M. Williams, David J. DeBrota, C. Richard Clark, Evian Gordon	40
11	Neurophysiologic Correlates of Side Effects in Normal Subjects Randomized to Venlafaxine or Placebo 2004 ·Neuropsychopharmacology ·Aimee M. Hunter, Andrew F. Leuchter, Melinda Morgan, Ian A. Cook, Michelle Abrams, (unknown), David J. DeBrota, William Z. Potter	20
12	An Item Response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies 2004 ·Journal of Psychiatric Research ·Kenneth Evans, Terrence Sills, David J. DeBrota, (unknown), Nina Engelhardt, Darcy A. Santor	48
13	Assessing and interpreting treatment effects in longitudinal clinical trials with missing data 2003 ·Biological Psychiatry ·Craig Mallinckrodt, T.M. Sanger, Sanjay Dubé, David J. DeBrota, Geert Molenberghs, Raymond J. Carroll, William Z. Potter, Gary D. Tollefson	188
14	The responsiveness of the Hamilton Depression Rating Scale 2000 ·Journal of Psychiatric Research ·Douglas E. Faries, John M. Herrera, (unknown), David J. DeBrota, Mark A. Demitrack, William Z. Potter	200
15	The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period 2000 ·Biometrics ·Ronald J. Landin, David J. DeBrota, Todd DeVries, William Z. Potter, Mark A. Demitrack	46
16	Comparison of Interactive Voice Response SF-36 to Self-Administered SF-36 and Personal Interview via Telephone SF-36. 1996 ·Europe PMC (PubMed Central) ·David J. DeBrota, (unknown), (unknown), Mark Kosinski, John E. Ware	2
17	In front of us 1994 ·International Journal of Bio-Medical Computing ·David J. DeBrota	3
18	Using discrete event simulation to evaluate housestaff work schedules 1990 ·Winter Simulation Conference ·Robert W. Klein, (unknown), Robert S. Dittus, David J. DeBrota	2
19	Visual interactive fitting of bounded Johnson distributions 1989 ·SIMULATION ·David J. DeBrota, Robert S. Dittus, Stephen D. Roberts, James R. Wilson	50
20	Input modeling with the Johnson system of distributions 1988 ·David J. DeBrota, Stephen D. Roberts, James J. Swain, Robert S. Dittus, James R. Wilson, Sekhar Venkatraman	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact